Endoscopic management of upper-tract urothelial carcinoma

Jay Raman, Rosa Park

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: Radical nephroureterectomy with an ipsilateral bladder cuff is the referent standard for management of muscle-invasive, high-grade, or bulky upper-tract urothelial carcinoma (UTUC). Nonetheless, certain patients with UTUC have imperative or elective indications for kidney preservation thereby lending to more conservative strategies for management of this disease. Areas covered: A review of the PubMED and Medline databases was performed to identify original scientific and review articles discussing retrograde ureteroscopic or percutaneous antegrade resection of UTUC tumors published between 1995 and 2016. Comparative studies with radical nephroureterectomy were also included. Expert commentary: Endoscopic ablative treatments via retrograde or antegrade approaches may appropriately treat small, solitary, and low risk UTUC tumors. Recurrences in the ipsilateral upper-tract and bladder distal to the original tumor can occur following nephron-sparing treatments and therefore a vigilant surveillance program with a compliant patient is essential when pursuing this treatment approach.

Original languageEnglish (US)
Pages (from-to)545-554
Number of pages10
JournalExpert Review of Anticancer Therapy
Volume17
Issue number6
DOIs
StatePublished - Jun 3 2017

Fingerprint

Carcinoma
Urinary Bladder
Neoplasms
Nephrons
Therapeutics
Databases
Kidney
Recurrence
Muscles
Conservative Treatment

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)

Cite this

@article{9d8e6fe52e3e406a88e93ab03403fc25,
title = "Endoscopic management of upper-tract urothelial carcinoma",
abstract = "Introduction: Radical nephroureterectomy with an ipsilateral bladder cuff is the referent standard for management of muscle-invasive, high-grade, or bulky upper-tract urothelial carcinoma (UTUC). Nonetheless, certain patients with UTUC have imperative or elective indications for kidney preservation thereby lending to more conservative strategies for management of this disease. Areas covered: A review of the PubMED and Medline databases was performed to identify original scientific and review articles discussing retrograde ureteroscopic or percutaneous antegrade resection of UTUC tumors published between 1995 and 2016. Comparative studies with radical nephroureterectomy were also included. Expert commentary: Endoscopic ablative treatments via retrograde or antegrade approaches may appropriately treat small, solitary, and low risk UTUC tumors. Recurrences in the ipsilateral upper-tract and bladder distal to the original tumor can occur following nephron-sparing treatments and therefore a vigilant surveillance program with a compliant patient is essential when pursuing this treatment approach.",
author = "Jay Raman and Rosa Park",
year = "2017",
month = "6",
day = "3",
doi = "10.1080/14737140.2017.1326823",
language = "English (US)",
volume = "17",
pages = "545--554",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "6",

}

Endoscopic management of upper-tract urothelial carcinoma. / Raman, Jay; Park, Rosa.

In: Expert Review of Anticancer Therapy, Vol. 17, No. 6, 03.06.2017, p. 545-554.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Endoscopic management of upper-tract urothelial carcinoma

AU - Raman, Jay

AU - Park, Rosa

PY - 2017/6/3

Y1 - 2017/6/3

N2 - Introduction: Radical nephroureterectomy with an ipsilateral bladder cuff is the referent standard for management of muscle-invasive, high-grade, or bulky upper-tract urothelial carcinoma (UTUC). Nonetheless, certain patients with UTUC have imperative or elective indications for kidney preservation thereby lending to more conservative strategies for management of this disease. Areas covered: A review of the PubMED and Medline databases was performed to identify original scientific and review articles discussing retrograde ureteroscopic or percutaneous antegrade resection of UTUC tumors published between 1995 and 2016. Comparative studies with radical nephroureterectomy were also included. Expert commentary: Endoscopic ablative treatments via retrograde or antegrade approaches may appropriately treat small, solitary, and low risk UTUC tumors. Recurrences in the ipsilateral upper-tract and bladder distal to the original tumor can occur following nephron-sparing treatments and therefore a vigilant surveillance program with a compliant patient is essential when pursuing this treatment approach.

AB - Introduction: Radical nephroureterectomy with an ipsilateral bladder cuff is the referent standard for management of muscle-invasive, high-grade, or bulky upper-tract urothelial carcinoma (UTUC). Nonetheless, certain patients with UTUC have imperative or elective indications for kidney preservation thereby lending to more conservative strategies for management of this disease. Areas covered: A review of the PubMED and Medline databases was performed to identify original scientific and review articles discussing retrograde ureteroscopic or percutaneous antegrade resection of UTUC tumors published between 1995 and 2016. Comparative studies with radical nephroureterectomy were also included. Expert commentary: Endoscopic ablative treatments via retrograde or antegrade approaches may appropriately treat small, solitary, and low risk UTUC tumors. Recurrences in the ipsilateral upper-tract and bladder distal to the original tumor can occur following nephron-sparing treatments and therefore a vigilant surveillance program with a compliant patient is essential when pursuing this treatment approach.

UR - http://www.scopus.com/inward/record.url?scp=85019927424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019927424&partnerID=8YFLogxK

U2 - 10.1080/14737140.2017.1326823

DO - 10.1080/14737140.2017.1326823

M3 - Review article

C2 - 28480774

AN - SCOPUS:85019927424

VL - 17

SP - 545

EP - 554

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 6

ER -